About Exact Imaging
Exact Imaging is a Healthcare company based in Markham (Canada) founded in 2013. It operates as a micro-ultrasound devices for prostate imaging and biopsies are developed. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Exact Imaging has raised $39.91 million across 6 funding rounds from investors including PMV, Vesalius Biocapital Partners and Veddis. Its Indian entity Ing Vysya Bank Limited reported revenue of ₹2,262 Cr. Exact Imaging offers products and services including ExactVu Micro-Ultrasound System, EV29L Transducer, and FusionVu. Its focus areas include Medical Devices and Diagnostic Imaging. Its competitors include KOELIS, Triopsy, Clariflow, Focal Healthcare and UROCAM and 1 more; 3 of its 6 listed competitors have raised funding.
Company details
Exact Imaging is engaged in the development and distribution of high-resolution micro-ultrasound systems, primarily for urological applications. The companys flagship product, the ExactVu system, is designed to assist urologists in performing targeted prostate biopsies within standard workflows. Solutions are provided for both high-resolution and conventional imaging needs, covering procedures such as abdominal, testicular, and large prostate imaging. The technology is utilized in the healthcare sector, specifically targeting diagnostic imaging challenges with innovative tools and protocols like PRI-MUS for evidence-based targeting.
- Headquarters Markham, Canada
- SectorsHealthcare
- Phone•••• ••••
- Website exactimaging.com
- Social LinkedIn X Facebook YouTube
- Legal Name Exact Imaging
- Date of Incorporation 29 Mar, 1930
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹2,262 Cr
FY 2024 · 0% YoY
- Total Equity Funding$39.91M (USD)
in 6 rounds
- Latest Funding Round$10M (USD), Series D
Feb 2026
- InvestorsPMV
& 5 more
Associated legal entities of Exact Imaging
Exact Imaging operates through Ing Vysya Bank Limited, a listed company (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ing Vysya Bank Limited Listed CIN L85110KA1930PLC000124 | Amalgamated | 29 Mar 1930 | Bangalore, Karnataka | ₹2,262 Cr | – | 11 | View details |
Products & Services of Exact Imaging
Exact Imaging offers a comprehensive portfolio of products and services, including ExactVu Micro-Ultrasound System, EV29L Transducer, and FusionVu.
High-resolution ultrasound system for targeted prostate biopsies.
Transducer used for high-resolution prostate imaging procedures.
Software for MRI and ultrasound fusion in biopsies.
Apps and channels of Exact Imaging
its YouTube channel Exact Imaging has 31 subscribers.
Funding Insights of Exact Imaging
Exact Imaging has successfully raised a total of $39.91M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $39.91M
- Total Rounds 6
- Last Round Series D — $10M
- Investors Count 6
All 6 funding rounds of Exact Imaging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2026 | $10M | Series D | – | iGan Partners | – |
| Nov 2019 | $244,385 | Series C | – | – | – |
| Feb 2019 | $7.61M | Series C | – | – | – |
| Jan 2017 | $16.06M | Series C | – | Lumira Ventures, Vesalius Biocapital Partners | |
| May 2014 | $6M | Series B | – | iGan Partners | |
| Jun 2013 | – | Series A | – | iGan Partners | – |
6 investors in total: 6 institutional.
Investors in Exact Imaging
Exact Imaging has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include PMV, Vesalius Biocapital Partners and Veddis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Lumira Ventures is engaged in life sciences venture capital investment. | – | lumiraventures.com | Toronto, Canada | |
Life sciences-focused VC firm investing in Europe and Canada | 2007 | vesaliusbiocapital.com | Strassen, Luxembourg | |
Private debt funds are managed across multiple sectors. | 2001 | pmv.eu | Brussels, Belgium | |
Healthcare-focused venture capital is provided by iGan Partners. | – | iganpartners.com | Toronto, Canada | |
Investment management and philanthropy services focused on long-term wealth growth and community impact. | 2006 | veddis.com | London, United Kingdom | |
Early-stage technology startups are supported through investments by MaRS IAF. | – | marsiaf.com | Canada |
Investor details for Exact Imaging
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ing Vysya Bank Limited (Exact Imaging)
Ing Vysya Bank Limited is the primary company behind Exact Imaging. The board of Ing Vysya Bank Limited currently have 11 directors; the longest-serving is Maddali Venkata Satya Apparao, appointed in 2007. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Maddali Venkata Satya Apparao DIN 00484877 | Company Secretary | 27 Jul 2007 | 19 yrs 2 mo | Ing Vysya Bank Limited |
| Santosh Desai DIN 01237902 | Director | 29 Apr 2008 | 18 yrs 5 mo | Ing Vysya Bank Limited |
| Meleveetil Damodaran DIN 02106990 | Director | 21 Jul 2008 | 18 yrs 3 mo | Ing Vysya Bank Limited |
| Vaughn Nigel Richtor DIN 00698356 | Director | 01 Jun 2009 | 17 yrs 4 mo | Ing Vysya Bank Limited |
| Vikram Talwar DIN 00416236 | Director | 20 Dec 2010 | 15 yrs 10 mo | Ing Vysya Bank Limited |
| Mark Edwin Newman DIN 03518417 | Director | 20 Apr 2011 | 15 yrs 6 mo | Ing Vysya Bank Limited |
| Jayant Mehrotra DIN 07681406 | CFO | 29 Apr 2014 | 12 yrs 5 mo | Ing Vysya Bank Limited |
| Alka Marezban Bharucha DIN 00114067 | Additional Director | 25 Jun 2014 | 12 yrs 3 mo | Ing Vysya Bank Limited |
| Adrianus Johannes Antonius Kas DIN 06853983 | Additional Director | 25 Jun 2014 | 12 yrs 3 mo | Ing Vysya Bank Limited |
| Kewal Kundanlal Handa DIN 00056826 | Additional Director | 12 Aug 2014 | 12 yrs 2 mo | Ing Vysya Bank Limited |
| David Han Lee Yong DIN 07015440 | Additional Director | 10 Nov 2014 | 11 yrs 11 mo | Ing Vysya Bank Limited |
People of Exact Imaging
22 people are tracked at Exact Imaging (7 in leadership, 15 in team).
| Name | Role | Group |
|---|---|---|
Randy AuCoin | President & CEO | Leadership |
Brian Wodlinger | VP, Engineering & Clinical | Leadership |
Russell Daling | Director, Manufacturing & Service | Leadership |
JAMES EDWARD TURNER | Head of Marketing Director | Leadership |
Kevin Maier, CPA, CA | Director of Finance | Leadership |
Gwendolyn Pinto | Director, RA & QA | Leadership |
Tim Heyer | Director Of Sales | Leadership |
Sandy Smith | Quality Management System Associate | Team |
Theresa McGrath | Manager Global Clinical Application Specialists | Team |
Evan Meikleham | Senior Software Engineer | Team |
Kevin Maier | Senior Manager, Finance | Team |
Ted Timar | Manager, Software and Architecture | Team |
Emma Beverley | Snr Quality Engineering Specialist | Team |
Luca Scalisi | Clinical Engineer | Team |
Andrei Lambert | Clinical Applications Specialist, North America | Team |
Na Li | Senior Quality Engineering Specialist | Team |
Ruth Aviles | Production Support Associate | Team |
Kyle Dunn | Field Service Representative - North America | Team |
Andrew Lewis | Senior Clinical Applications Specialist Europe | Team |
Jeff Zhang | Sr. Electronics Developer | Team |
2 more people are available in the full profile.
Complete people profiles for Exact Imaging
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Exact Imaging
Figures of Ing Vysya Bank Limited, the primary company behind Exact Imaging, for FY 2024. Revenue was ₹2,262 Cr (0% year on year). Revenue has grown at a compounded annual rate of +7% over three years and +4% over five years.
- ₹2,262 CrRevenue · FY 2024 · 0% YoY
- ₹192 CrPaid-up capital
- +7%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ing Vysya Bank Limited are on its company page.
Detailed financial statements for Exact Imaging
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Exact Imaging
3 dated milestones of Exact Imaging across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Exact Imaging is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $10.0M.
Competitors of Exact Imaging
Exact Imaging has 6 listed competitors in our database, 3 of them funded. They include KOELIS, Triopsy, Clariflow, Focal Healthcare and UROCAM, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| koelis.com | 2006 | Meylan, France | – | – | MRI/ultrasound fusion biopsy systems for prostate care are developed. | |
| triopsy.com | 2012 | Aurora, United States | $4.14M | – | Medical device for precise prostate cancer diagnosis is developed. | |
| clariflow.com | 2014 | New York, United States | $100,000 | – | Provides DIY test kits for benign prostatic hyperplasia (BPH). | |
| focalhealthcare.com | 2014 | Toronto, Canada | $870,000 | – | MRI/TRUS fusion systems for prostate biopsy guidance are developed. | |
| urocam.ca | 2017 | Vaughan, Canada | – | – | Develops innovative medical devices for prostate cancer diagnosis. | |
| cellda.com | 2018 | Uppsala, Sweden | – | – | Develops software tools for accurate prostate cancer diagnosis and analysis. |
Detailed competitors of Exact Imaging
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Exact Imaging
The website of Exact Imaging (exactimaging.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▼ 8.8% vs previous month
Top companies in Oncology
10 companies that operate in the same segment as Exact Imaging (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Exact Imaging
Complete news archive for Exact Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exact Imaging
Exact Imaging was founded in 2013.
Exact Imaging is headquartered in Markham, Canada. It is registered at Markham, Ontario, Canada.
Exact Imaging is a funded company, having raised a total of $39.91M across 6 funding rounds to date.
The primary company behind Exact Imaging, Ing Vysya Bank Limited, reported revenue of ₹2,262 Cr for FY 2024, down 0% year on year.
Exact Imaging is engaged in the development and distribution of high-resolution micro-ultrasound systems, primarily for urological applications. The companys flagship product, the ExactVu system, is designed to assist urologists in performing targeted prostate biopsies within standard workflows. Solutions are provided for both high-resolution and conventional imaging needs, covering procedures such as abdominal, testicular, and large prostate imaging. The technology is utilized in the healthcare sector, specifically targeting diagnostic imaging challenges with innovative tools and protocols like PRI-MUS for evidence-based targeting.
Exact Imaging's top competitors include KOELIS, Triopsy and Focal Healthcare.
Exact Imaging offers ExactVu Micro-Ultrasound System, EV29L Transducer, and FusionVu.
Exact Imaging has 6 investors. Key investors include PMV, Vesalius Biocapital Partners, Veddis, Lumira Ventures, and iGan Partners.
Exact Imaging operates through Ing Vysya Bank Limited.
The legal entities of Exact Imaging currently have 11 directors, including Mark Edwin Newman, Vikram Talwar, Vaughn Nigel Richtor and others.